ABSTRACT
Dictyostelium plasmids Dgp1 and Dfp1, two members of the Ddp2 plasmid family, are 86% identical in nucleotide sequence. These small (4481 and 5015 bp), high copy number, nuclear plasmids carry both a gene homologous to the Ddp2 rep gene and a long 0.47- to 0. 48-kb inverted repeat region. Their Rep proteins are 82.8% identical in amino acid sequence and carry all 10 of the conserved peptide sequence motifs found in the Ddp2 family Rep proteins. Unlike other members of this family, Dgp1 carries two copies and Dfp1 carries four copies of a 162- to 166-bp direct repeat element. Both the direct and inverted repeat elements, as well as the promoter of the rep gene, are highly conserved (81 to 90% identical) between Dgp1 and Dfp1. In contrast, these regions are not highly conserved and the Rep proteins are only about 40% identical among the other known members of the plasmid family.
Subject(s)
DNA Helicases/genetics , DNA-Binding Proteins , Dictyostelium/genetics , Plasmids , Protozoan Proteins/genetics , Trans-Activators/genetics , Amino Acid Sequence , Animals , Molecular Sequence Data , Repetitive Sequences, Nucleic Acid , Sequence Homology, Amino AcidABSTRACT
A 5 MHz continuous-wave Doppler probe was used intraoperatively to evaluate 25 in situ saphenous vein bypass grafts. At least one arteriovenous fistula per case and five retained competent posterior valvular leaflets were identified before completion angiography. The Doppler was able to distinguish a retained valve from an arteriovenous fistula on clinical grounds but not by waveform analysis. Intraoperative assessment of in situ saphenous vein bypass grafts with the continuous-wave Doppler can identify retained valves that might be missed by angiography. It can reduce the number of angiograms needed to demonstrate a technically perfect result, thus saving operative time and contrast agent load to the patient.
Subject(s)
Arterial Occlusive Diseases/surgery , Femoral Artery/surgery , Intraoperative Care , Leg/blood supply , Saphenous Vein/transplantation , Ultrasonography , Arteriovenous Fistula/diagnosis , Graft Occlusion, Vascular/diagnosis , HumansABSTRACT
Giant lymph node hyperplasia (GLNH) is a rare tumor. The authors have reviewed the literature and brought the reported total to 235 cases. There are two types of GLNH, a hyaline-vascular and plasma-cell type. The usual presentation is as an asymptomatic solitary mass, though multicentric lesions are found. Symptoms are most frequent with the plasma-cell type. A syndrome of anemia, growth retardation, and hypergammaglobulinemia is seen in the plasma-cell type in children. The etiology is unknown, though immunologic studies indicate a reactive phenomenon. Radiologic studies are nonspecific. Therapy is surgical excision, which is usually curative.
